Leukemia Fusion Protein Hijacks RNA Modifier to Shield Cancer Stem Cells
Understanding how leukemia stem cells evade elimination is one of the central puzzles in blood cancer biology — and a key reason why acute myeloid leukemia…
Found 2067 results for "cancer"
Understanding how leukemia stem cells evade elimination is one of the central puzzles in blood cancer biology — and a key reason why acute myeloid leukemia…
Understanding exactly how cancer chemotherapy drugs inflict lethal DNA damage has long been constrained by the difficulty of modeling that damage in living…
The delivery mechanism of mRNA vaccines has quietly been one of the most consequential—and least discussed—variables in vaccine performance. Lipid…
For the roughly one-third of EGFR-mutated lung cancer patients who also carry TP53 mutations — a genomic co-occurrence historically linked to faster…
For patients carrying both EGFR and TP53 mutations in advanced non-small cell lung cancer, treatment resistance has historically arrived frustratingly early…
For patients living with the most common genomic subtype of advanced lung cancer, a fundamental treatment question is sharpening: does everyone need more…
For men diagnosed with low-risk prostate cancer, watchful waiting rather than immediate treatment has become the clinical standard — yet adoption of this…
When a treatment gains clinical momentum faster than the evidence supporting it, patient outcomes can diverge dramatically from intent. Focal therapy — the…
Prostate cancer treatment sits at an uncomfortable intersection of clinical uncertainty and commercial enthusiasm, where novel interventions often earn…
Colorectal cancer remains the second-leading cause of cancer death in the United States, yet screening rates lag well behind those for breast and cervical…
Uterine cancer is the most common gynecologic malignancy in the United States, and its incidence has been climbing for decades — yet environmental…
Colorectal cancer remains one of the most preventable malignancies when caught early, yet its detection depends heavily on colonoscopists correctly…
Mammographic breast density has long been recognized as one of the strongest independent risk factors for breast cancer—yet the biological mechanisms…
One of the most stubborn frontiers in cancer immunotherapy is making powerful T cell treatments accessible beyond academic cancer centers—and beyond a…
The immune system's ability to recognize and destroy cancer cells hinges on a delicate molecular negotiation — and tumors have evolved sophisticated ways to…
Understanding how fatty liver disease progresses from lipid accumulation to cirrhosis or liver cancer has long been hampered by a fragmented preclinical…
Antibiotic-resistant infections kill an estimated 1.27 million people annually, and MRSA stands among the most dangerous offenders — partly because its…
One of the most stubborn barriers to effective cancer immunotherapy is not the tumor itself — it is the immune system giving up. T-cell exhaustion…
For the roughly 0.5% of the population carrying cerebral cavernous malformations (CCMs), the threat of seizure or hemorrhagic stroke currently has no medical…
Hormone receptor-positive breast cancer is the most common breast cancer subtype, and for decades its treatment rested on a relatively stable pharmacological…